StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health cash

Cash and short-term investments held at the end of each period.

Aspira Women's Health's cash was $477.00K at Jun 30, 2026. For fiscal 2025 it was $1.76M, down 0.8% from the year before. Over ten years it grew -21.0% a year on average. The highest annual figure on record is $37.43M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.76M-0.8%
FY2024Dec 31, 2024$1.77M-31.9%
FY2023Dec 31, 2023$2.60M-80.8%
FY2022Dec 31, 2022$13.56M-63.8%
FY2021Dec 31, 2021$37.43M+125.1%
FY2020Dec 31, 2020$16.63M+42.1%
FY2019Dec 31, 2019$11.70M+25.0%
FY2018Dec 31, 2018$9.36M+69.0%
FY2017Dec 31, 2017$5.54M+5.7%
FY2016Dec 31, 2016$5.24M-71.9%
FY2015Dec 31, 2015$18.64M-18.8%
FY2014Dec 31, 2014$22.97M-22.2%
FY2013Dec 31, 2013$29.50M+268.5%
FY2012Dec 31, 2012$8.01M-64.4%
FY2011Dec 31, 2011$22.48M-1.9%
FY2010Dec 31, 2010$22.91M+566.1%
FY2009Dec 31, 2009$3.44M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$477.00K-69.1%
Q1 FY2026Mar 31, 2026$1.34M-59.4%
Q4 FY2025Dec 31, 2025$1.76M-0.8%
Q3 FY2025Sep 30, 2025$3.81M+78.6%
Q2 FY2025Jun 30, 2025$1.55M+60.6%
Q1 FY2025Mar 31, 2025$3.31M-3.0%
Q4 FY2024Dec 31, 2024$1.77M-31.9%
Q3 FY2024Sep 30, 2024$2.13M-58.2%
Q2 FY2024Jun 30, 2024$962.00K-77.3%
Q1 FY2024Mar 31, 2024$3.41M-54.7%
Q4 FY2023Dec 31, 2023$2.60M-80.8%
Q3 FY2023Sep 30, 2023$5.10M-75.2%
Q2 FY2023Jun 30, 2023$4.25M-79.3%
Q1 FY2023Mar 31, 2023$7.54M-71.9%
Q4 FY2022Dec 31, 2022$13.56M-63.8%
Q3 FY2022Sep 30, 2022$20.55M-54.2%
Q2 FY2022Jun 30, 2022$20.48M-61.4%
Q1 FY2022Mar 31, 2022$26.86M-54.8%
Q4 FY2021Dec 31, 2021$37.43M+125.1%
Q3 FY2021Sep 30, 2021$44.87M+138.2%
Q2 FY2021Jun 30, 2021$52.99M+384.6%
Q1 FY2021Mar 31, 2021$59.37M+630.1%
Q4 FY2020Dec 31, 2020$16.63M+42.1%
Q3 FY2020Sep 30, 2020$18.84M+28.7%
Q2 FY2020Jun 30, 2020$10.94M-32.4%
Q1 FY2020Mar 31, 2020$8.13M+31.7%
Q4 FY2019Dec 31, 2019$11.70M+25.0%
Q3 FY2019Sep 30, 2019$14.64M+24.5%
Q2 FY2019Jun 30, 2019$16.18M+14.5%
Q1 FY2019Mar 31, 2019$6.17M+99.0%
Q4 FY2018Dec 31, 2018$9.36M+69.0%
Q3 FY2018Sep 30, 2018$11.76M+51.7%
Q2 FY2018Jun 30, 2018$14.14M+134.5%
Q1 FY2018Mar 31, 2018$3.10M-60.7%
Q4 FY2017Dec 31, 2017$5.54M+5.7%
Q3 FY2017Sep 30, 2017$7.75M-4.1%
Q2 FY2017Jun 30, 2017$6.03M–
Q1 FY2017Mar 31, 2017$7.90M–
Q4 FY2016Dec 31, 2016$5.24M–
Q3 FY2016Sep 30, 2016$8.08M–

More Aspira Women's Health figures

See a number that looks wrong?